RaySearch Laboratories AB ser. B (0GRZ)

Currency in SEK
270.25
+3.75(+1.41%)
Closed·
0GRZ Scorecard
Full Analysis
Impressive gross profit margins
0GRZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
265.00270.25
52 wk Range
148.20369.50
Key Statistics
Bid/Ask
263.50 / 277.00
Prev. Close
266.5
Open
266.5
Day's Range
265-270
52 wk Range
148.2-369.5
Volume
6.91K
Average Volume (3m)
11.36K
1-Year Change
73.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0GRZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

RaySearch Laboratories AB ser. B Company Profile

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Compare 0GRZ to Peers and Sector

Metrics to compare
0GRZ
Peers
Sector
Relationship
P/E Ratio
48.0x22.2x−0.6x
PEG Ratio
1.760.070.00
Price/Book
10.9x2.2x2.6x
Price / LTM Sales
7.4x2.0x3.3x
Upside (Analyst Target)
-9.7%38.0%
Fair Value Upside
Unlock19.2%4.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.63%
Dividend Yield
1.12%
Industry Median 1.97%
Annualised payout
3.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
0.90 / 1.23
Revenue / Forecast
304.90M / 317.53M
EPS Revisions
Last 90 days

0GRZ Income Statement

People Also Watch

162.40
BETSb
+1.12%
272.00
ESLX
0.00%
363.9
NOVOb
+2.19%
296.00
BONEX
+2.99%
243.50
SKAb
+1.93%

FAQ

What Stock Exchange Does RaySearch Laboratories AB ser. B Trade On?

RaySearch Laboratories AB ser. B is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for RaySearch Laboratories AB ser. B?

The stock symbol for RaySearch Laboratories AB ser. B is "0GRZ."

What Is the RaySearch Laboratories AB ser. B Market Cap?

As of today, RaySearch Laboratories AB ser. B market cap is 9.22B.

What Is RaySearch Laboratories AB ser. B's Earnings Per Share (TTM)?

The RaySearch Laboratories AB ser. B EPS (TTM) is 5.63.

When Is the Next RaySearch Laboratories AB ser. B Earnings Date?

RaySearch Laboratories AB ser. B will release its next earnings report on 06 Nov 2025.

From a Technical Analysis Perspective, Is 0GRZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has RaySearch Laboratories AB ser. B Stock Split?

RaySearch Laboratories AB ser. B has split 1 times.

How Many Employees Does RaySearch Laboratories AB ser. B Have?

RaySearch Laboratories AB ser. B has 431 employees.

What is the current trading status of RaySearch Laboratories AB ser. B (0GRZ)?

As of 24 Aug 2025, RaySearch Laboratories AB ser. B (0GRZ) is trading at a price of 270.25, with a previous close of 266.50. The stock has fluctuated within a day range of 265.00 to 270.00, while its 52-week range spans from 148.20 to 369.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.